BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83−0.10 (-10.38%)
Close on Nov 12, 2026Market cap $12.50MP/E –Yield –
BioCardia cash
Cash and short-term investments held at the end of each period.
BioCardia's cash was $2.22M at Sep 30, 2026. For fiscal 2025 it was $2.50M, up 5.3% from the year before. Over ten years it grew -3.5% a year on average. The highest annual figure on record is $21.41M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.50M | +5.3% |
| FY2024 | Dec 31, 2024 | $2.37M | +115.0% |
| FY2023 | Dec 31, 2023 | $1.10M | -85.0% |
| FY2022 | Dec 31, 2022 | $7.36M | -42.8% |
| FY2021 | Dec 31, 2021 | $12.87M | -39.9% |
| FY2020 | Dec 31, 2020 | $21.41M | +283.3% |
| FY2019 | Dec 31, 2019 | $5.59M | +4.2% |
| FY2018 | Dec 31, 2018 | $5.36M | -57.8% |
| FY2017 | Dec 31, 2017 | $12.69M | -40.6% |
| FY2016 | Dec 31, 2016 | $21.35M | +500.3% |
| FY2015 | Dec 31, 2015 | $3.56M | +11.7% |
| FY2014 | Dec 31, 2014 | $3.18M | -76.1% |
| FY2013 | Dec 31, 2013 | $13.30M | +0.2% |
| FY2012 | Dec 31, 2012 | $13.27M | +4.7% |
| FY2011 | Dec 31, 2011 | $12.68M | +9882.7% |
| FY2010 | Dec 31, 2010 | $127.00K | -97.4% |
| FY2009 | Dec 31, 2009 | $4.97M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.22M | -57.9% |
| Q2 FY2026 | Jun 30, 2026 | $4.12M | +320.1% |
| Q1 FY2026 | Mar 31, 2026 | $951.00K | +0.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.50M | +5.3% |
| Q3 FY2025 | Sep 30, 2025 | $5.29M | +7.2% |
| Q2 FY2025 | Jun 30, 2025 | $980.00K | -31.0% |
| Q1 FY2025 | Mar 31, 2025 | $949.00K | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.37M | +115.0% |
| Q3 FY2024 | Sep 30, 2024 | $4.93M | +168.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.42M | -67.0% |
| Q1 FY2024 | Mar 31, 2024 | $949.00K | -80.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.10M | -85.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.84M | -72.5% |
| Q2 FY2023 | Jun 30, 2023 | $4.31M | -50.0% |
| Q1 FY2023 | Mar 31, 2023 | $4.86M | -27.5% |
| Q4 FY2022 | Dec 31, 2022 | $7.36M | -42.8% |
| Q3 FY2022 | Sep 30, 2022 | $6.67M | -58.0% |
| Q2 FY2022 | Jun 30, 2022 | $8.61M | -53.5% |
| Q1 FY2022 | Mar 31, 2022 | $6.70M | -68.8% |
| Q4 FY2021 | Dec 31, 2021 | $12.87M | -39.9% |
| Q3 FY2021 | Sep 30, 2021 | $15.89M | +114.9% |
| Q2 FY2021 | Jun 30, 2021 | $18.54M | +67.3% |
| Q1 FY2021 | Mar 31, 2021 | $21.50M | +731.2% |
| Q4 FY2020 | Dec 31, 2020 | $21.41M | +283.3% |
| Q3 FY2020 | Sep 30, 2020 | $7.39M | -17.0% |
| Q2 FY2020 | Jun 30, 2020 | $11.09M | +2044.3% |
| Q1 FY2020 | Mar 31, 2020 | $2.59M | -8.8% |
| Q4 FY2019 | Dec 31, 2019 | $5.59M | +4.2% |
| Q3 FY2019 | Sep 30, 2019 | $8.91M | +84.9% |
| Q2 FY2019 | Jun 30, 2019 | $517.00K | -92.4% |
| Q1 FY2019 | Mar 31, 2019 | $2.84M | -70.6% |
| Q4 FY2018 | Dec 31, 2018 | $5.36M | -57.8% |
| Q3 FY2018 | Sep 30, 2018 | $4.82M | -68.1% |
| Q2 FY2018 | Jun 30, 2018 | $6.83M | -59.6% |
| Q1 FY2018 | Mar 31, 2018 | $9.65M | -49.3% |
| Q4 FY2017 | Dec 31, 2017 | $12.69M | -40.6% |
| Q3 FY2017 | Sep 30, 2017 | $15.13M | – |
| Q2 FY2017 | Jun 30, 2017 | $16.91M | – |
| Q1 FY2017 | Mar 31, 2017 | $19.03M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.35M | – |
See a number that looks wrong?